CanSino Biologics Inc.

OTCPK:CASB.F Stock Report

Market Cap: US$1.4b

CanSino Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CASB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Dec 24BuyUS$71,818Shou-Bai ChaoIndividual18,000US$3.99
27 Nov 24BuyUS$105,777Xuefeng YuIndividual30,000US$3.53
26 Sep 24BuyUS$56,057Xuefeng YuIndividual20,000US$2.80
09 Sep 24BuyUS$47,116Xuefeng YuIndividual20,000US$2.36
09 Sep 24BuyUS$70,490Shou-Bai ChaoIndividual30,000US$2.35
25 Jul 24BuyUS$2,329Jing WangIndividual1,000US$2.33
24 Jul 24BuyUS$23,781Xuefeng YuIndividual10,000US$2.38
24 Jul 24BuyUS$16,535Jing WangIndividual7,000US$2.36
15 Jul 24BuyUS$7,287Jing WangIndividual3,000US$2.43
12 Jul 24BuyUS$37,430Shou-Bai ChaoIndividual15,000US$2.50
10 Jul 24BuyUS$12,000Shou-Bai ChaoIndividual5,000US$2.40
09 Jul 24BuyUS$48,281Xuefeng YuIndividual20,000US$2.41
09 Jul 24BuyUS$18,632Jing WangIndividual7,800US$2.39

Insider Trading Volume

Insider Buying: CASB.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CASB.F?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme277,6500.112%
Private Companies7,516,5383.04%
Institutions25,607,91710.4%
Individual Insiders70,453,94228.5%
General Public143,187,75458%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.28%
Xuefeng Yu
17,974,200US$105.4m-39.1%no data
7.27%
Tao Zhu
17,962,400US$105.3m0%no data
6.94%
Dongxu Qiu
17,134,400US$100.4m-39.3%no data
6.61%
Huihua Mao
16,334,200US$95.8m-39.8%no data
3.04%
Qm29 Limited
7,516,538US$44.1m0%no data
1.95%
Goldman Sachs Group, Investment Banking and Securities Investments
4,809,877US$28.2m0%0.01%
1.54%
The Vanguard Group, Inc.
3,804,623US$22.3m0.79%no data
1.17%
SDIC Innovation Investment Management Co., Ltd.
2,883,810US$16.9m0%1.48%
0.7%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,732,962US$10.2m0%no data
0.62%
GF Fund Management Co., Ltd.
1,534,311US$9.0m0%0.01%
0.6%
Bosera Asset Management Co., Ltd.
1,490,170US$8.7m0%0.02%
0.58%
BlackRock, Inc.
1,442,163US$8.5m2.07%no data
0.56%
Barclays PLC Private Banking & Investment Banking Investment
1,395,072US$8.2m0%0.01%
0.52%
China Merchants Fund Management Company Ltd.
1,291,998US$7.6m0%0.05%
0.36%
Capital Research and Management Company
900,919US$5.3m0%no data
0.34%
Yinhua Fund Management Co., Ltd.
848,680US$5.0m0%0.04%
0.27%
Zhongqi Shao
675,000US$4.0m0%no data
0.19%
Enterprise Annuity Plan of Industrial and Commercial Bank of China Co., Ltd
465,025US$2.7m0%2.5%
0.16%
Dimensional Fund Advisors LP
399,793US$2.3m0%no data
0.12%
First Trust Advisors LP
289,136US$1.7m0%no data
0.11%
Cansino Biologics Inc., ESOP
277,650US$1.6m0%no data
0.11%
China Southern Asset Management Co., Ltd.
269,027US$1.6m0%no data
0.097%
Zhong Ou Fund Management Co., Ltd
240,600US$1.4m0%no data
0.088%
Fullgoal Fund Management Co. Ltd.
216,176US$1.3m0%no data
0.076%
China Asset Management Co. Ltd.
188,787US$1.1m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 19:25
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CanSino Biologics Inc. is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Lijian ZhaoChina International Capital Corporation Limited
Hangci ZhengChina International Capital Corporation Limited